YC Companies/Winter 2022/Actipulse Neuroscience
Actipulse Neuroscience logo

Actipulse Neuroscience

Bringing non-invasive brain stimulation from the hospital to the home

Winter 2022Healthcare / Healthcare -> Medical DevicesCambridge, MA, USA; Mexico City, CDMX, Mexico38 employees
Mental Health Tech
Neurotechnology
Medical Devices

About

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Founders (2)

Adrien Châtillon
Founder
Gabriel Villafuerte
Founder

Details

Status
Active
Stage
Early
Team Size
38
Regions
United States of America, Mexico, America / Canada, Latin America, Remote, Partly Remote